VolitionRx Ltd
VNRX
12 hedge funds and large institutions have $4.05M invested in VolitionRx Ltd in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
33% more funds holding
Funds holding: 9 → 12 (+3)
0.02% less ownership
Funds ownership: 0.26% → 0.24% (-0.02%)
5% less capital invested
Capital invested by funds: $4.25M → $4.05M (-$198K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$21.2K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$13.6K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.21K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$6.02K |
| 5 |
BlackRock
New York
|
+$4.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$144K |
| 2 |
Millennium Management
New York
|
-$68.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$25.3K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$21K |
VNRX Hedge Fund Activity: Q4 2015 in Review
12 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2015, worth a combined $4.05M — down 4.7% from $4.25M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VNRX positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $21.2K. The largest seller was Goldman Sachs, cutting an estimated $144K.
- 12 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2015, up from 9 in Q3 2015.
- Funds reported $4.05M of VolitionRx Ltd stock for Q4 2015, down 4.7% quarter-over-quarter.
- 4 funds opened new VolitionRx Ltd positions in Q4 2015 and 1 closed out, a net change of +3 holders.
- The largest VolitionRx Ltd buyer in Q4 2015 was Morgan Stanley, an estimated $21.2K added.
- The largest VolitionRx Ltd seller in Q4 2015 was Goldman Sachs, an estimated $144K sold.
Based on aggregated 13F filings for Q4 2015.